EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Acute Myocardial Infarction
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Enrollment
- 35
- Locations
- 1
- Primary Endpoint
- Characterizing type 2 myocardial infarction associated with CoV-2 SARS infection
- Last Updated
- 5 years ago
Overview
Brief Summary
The COVID-19 pandemic highlights the importance of the prognosis of co-morbidities, such as coronary artery disease, which significantly increase the risk of mortality in patients infected with SARS-CoV2. Investigators have recently studied the complex links between respiratory infections, particularly pneumonia, and type 2 myocardial infarction (MI) in many respects. The etiology of type 2 MI is based on an imbalance of myocardial oxygen supply/need in the absence of rupture/erosion of atheromatous plaques. Based on the RICO survey data, the investigators investigated whether COVID-19-related sepsis and/or respiratory failure could be an underlying mechanism of MI2.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without pneumonia
- •patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without COVID 19
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Characterizing type 2 myocardial infarction associated with CoV-2 SARS infection
Time Frame: Through study completion, an average of 1 year